Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Prepaid Assets (2021 - 2026)

Axsome Therapeutics' Prepaid Assets history spans 6 years, with the latest figure at $23.5 million for Q1 2026.

  • On a quarterly basis, Prepaid Assets rose 46.95% to $23.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $23.5 million, a 46.95% increase, with the full-year FY2025 number at $13.7 million, up 13.97% from a year prior.
  • Prepaid Assets hit $23.5 million in Q1 2026 for Axsome Therapeutics, up from $13.7 million in the prior quarter.
  • Over the last five years, Prepaid Assets for AXSM hit a ceiling of $23.5 million in Q1 2026 and a floor of $2.1 million in Q1 2022.
  • Historically, Prepaid Assets has averaged $10.4 million across 5 years, with a median of $11.8 million in 2024.
  • Biggest five-year swings in Prepaid Assets: surged 6040.97% in 2022 and later increased 13.97% in 2025.
  • Tracing AXSM's Prepaid Assets over 5 years: stood at $2.8 million in 2022, then soared by 191.8% to $8.1 million in 2023, then skyrocketed by 47.6% to $12.0 million in 2024, then grew by 13.97% to $13.7 million in 2025, then surged by 72.32% to $23.5 million in 2026.
  • Business Quant data shows Prepaid Assets for AXSM at $23.5 million in Q1 2026, $13.7 million in Q4 2025, and $19.8 million in Q3 2025.